These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 31972394

  • 1. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
    Said MA, Eldehna WM, Nocentini A, Fahim SH, Bonardi A, Elgazar AA, Kryštof V, Soliman DH, Abdel-Aziz HA, Gratteri P, Abou-Seri SM, Supuran CT.
    Eur J Med Chem; 2020 Mar 01; 189():112019. PubMed ID: 31972394
    [Abstract] [Full Text] [Related]

  • 2. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
    Ghorab MM, Soliman AM, Bua S, Supuran CT.
    Bioorg Chem; 2021 Feb 01; 107():104618. PubMed ID: 33485104
    [Abstract] [Full Text] [Related]

  • 3. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation.
    Abdelrahman MA, Eldehna WM, Nocentini A, Ibrahim HS, Almahli H, Abdel-Aziz HA, Abou-Seri SM, Supuran CT.
    J Enzyme Inhib Med Chem; 2020 Dec 01; 35(1):298-305. PubMed ID: 31809607
    [Abstract] [Full Text] [Related]

  • 4. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
    Allam HA, Fahim SH, F Abo-Ashour M, Nocentini A, Elbakry ME, Abdelrahman MA, Eldehna WM, Ibrahim HS, Supuran CT.
    Eur J Med Chem; 2019 Oct 01; 179():547-556. PubMed ID: 31276899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies.
    Alkhaldi AAM, Al-Sanea MM, Nocentini A, Eldehna WM, Elsayed ZM, Bonardi A, Abo-Ashour MF, El-Damasy AK, Abdel-Maksoud MS, Al-Warhi T, Gratteri P, Abdel-Aziz HA, Supuran CT, El-Haggar R.
    Eur J Med Chem; 2020 Dec 01; 207():112745. PubMed ID: 32877804
    [Abstract] [Full Text] [Related]

  • 11. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
    El-Azab AS, Abdel-Aziz AA, Bua S, Nocentini A, AlSaif NA, Alanazi MM, El-Gendy MA, Ahmed HEA, Supuran CT.
    J Enzyme Inhib Med Chem; 2020 Dec 01; 35(1):733-743. PubMed ID: 32189526
    [Abstract] [Full Text] [Related]

  • 12. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS, Allam HA, Mahmoud WR, Bonardi A, Nocentini A, Gratteri P, Ibrahim ES, Abdel-Aziz HA, Supuran CT.
    Eur J Med Chem; 2018 May 25; 152():1-9. PubMed ID: 29684705
    [Abstract] [Full Text] [Related]

  • 13. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B, Sławiński J, Szafrański K, Angeli A, Supuran CT, Kawiak A, Wieczór M, Zielińska J, Bączek T, Bartoszewska S.
    Eur J Med Chem; 2018 Jan 01; 143():1931-1941. PubMed ID: 29146134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
    Buza A, Türkeş C, Arslan M, Demir Y, Dincer B, Nixha AR, Beydemir Ş.
    Int J Biol Macromol; 2023 Jun 01; 239():124232. PubMed ID: 37001773
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors.
    Al-Wahaibi LH, Youssif BGM, Taher ES, Abdelazeem AH, Abdelhamid AA, Marzouk AA.
    Molecules; 2021 Aug 04; 26(16):. PubMed ID: 34443307
    [Abstract] [Full Text] [Related]

  • 19. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A, Bonardi A, Lomelino C, Osman SM, ALOthman ZA, Eldehna WM, El-Haggar R, McKenna R, Nocentini A, Supuran CT.
    Eur J Med Chem; 2020 Mar 15; 190():112112. PubMed ID: 32044580
    [Abstract] [Full Text] [Related]

  • 20. Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors.
    Abdelaal HI, Mohamed AR, Abo-Ashour MF, Giovannuzzi S, Fahim SH, Abdel-Aziz HA, Supuran CT, Abou-Seri SM.
    Bioorg Chem; 2024 Nov 15; 152():107759. PubMed ID: 39213797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.